NCT06670898

A Study of Absorption, Metabolism, Excretion of [14C]-NS-580 in Healthy Male Subjects

A Phase 1, Open-label Study of the Absorption, Metabolism, Excretion of [14C]-NS-580 Following a Single Oral Dose in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 8 (actual)
• Sponsor: Nippon Shinyaku Co., Ltd. · Industry
• Sex: Male
• Age: 35 Years – 60 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study was to determine the absorption, metabolism, and excretion of radioactivity and to characterize and determine, where possible, the metabolites present in plasma, urine, and faeces in healthy male subjects following a single oral administration of \[14C\]-NS-580.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	[14C] NS-580	Oral suspension

Timeline

• Start date: 2023-11-08
• Primary completion: 2024-01-18
• Completion: 2024-01-18
• First posted: 2024-11-01
• Last updated: 2024-11-01

Locations

1 site across 1 country: United Kingdom